Hodgkin disease/lymphoma
J Natl Compr Canc Netw
.
2008 Jul;6(6):594-622.
doi: 10.6004/jnccn.2008.0046.
Authors
Richard T Hoppe
1
,
Ranjana Hira Advani
,
Richard F Ambinder
,
Philip J Bierman
,
Clara D Bloomfield
,
Kristie Blum
,
Bouthaina Dabaja
,
Benjamin Djulbegovic
,
Andres Forero
,
Leo I Gordon
,
Francisco J Hernandez-Ilizaliturri
,
Melissa M Hudson
,
Mark S Kaminski
,
Gena Love
,
David G Maloney
,
David Mansur
,
Peter M Mauch
,
Joseph O Moore
,
Russell J Schilder
,
Lawrence M Weiss
,
Jane N Winter
,
Joachim Yahalom
,
Andrew D Zelenetz
;
National Comprehensive Cancer Network
Affiliation
1
Stanford Comprehensive Cancer Center, USA.
PMID:
18597713
DOI:
10.6004/jnccn.2008.0046
No abstract available
Publication types
Practice Guideline
MeSH terms
Antineoplastic Agents / therapeutic use
Hodgkin Disease / diagnosis
Hodgkin Disease / pathology
Hodgkin Disease / therapy*
Humans
Lymphoma / diagnosis
Lymphoma / pathology
Lymphoma / therapy*
Substances
Antineoplastic Agents